Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 3/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1577062 | 1.00 | CYP3A4 (0.41) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL14927229 | 0.89 | CYP3A4 (0.33) | CYP3A4TDP1 | |
| SCHEMBL27343 | 0.89 | CYP3A4 (0.50) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL4450096 | 0.87 | CYP3A4 (0.32) | CYP3A4TDP1 | |
| Phosphine SCHEMBL25423478 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL723376 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL9803491 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL22749137 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL1705969 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 | |
| SCHEMBL8850573 | 0.86 | CYP3A4 (0.47) | CYP3A4TDP1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4289809-A | DEACTIVATION FOR BETTER SEPARATION OF POLAR COMPOUNDS | SCM CORPORATION (US) | 1981-09-15 | — | — | US | claimed |
| US-4209554-A | PHOSPHONIUM SALTS | SCM CORPORATION (US) | 1980-06-24 | — | — | US | claimed |
| EP-3583211-B1 | METHOD FOR THE SYNTHESIS OF DNA CONJUGATES BY MICELLAR CATALYSIS | UNIV DORTMUND TECH (DE) | 2024-04-10 | — | — | EP | disclosed |
| US-11407993-B2 | Method for the synthesis of DNA conjugates by micellar catalysis | TECHNISCHE UNIVERSITAET DORTMUND (DE) | 2022-08-09 | — | — | US | disclosed |
| US-20220002712-A1 | METHOD FOR THE SYNTHESIS OF DNA CONJUGATES BY MICELLAR CATALYSIS | TECHNISCHE UNIVERSITÄT DORTMUND (DE) | 2022-01-06 | — | — | US | disclosed |
| EP-1753708-B1 | NOVEL SIRTUIN ACTIVATING COMPOUNDS AND METHODS FOR MAKING THE SAME | UNIV BRIGHAM YOUNG (US) | 2018-02-21 | — | — | EP | disclosed |
| US-8841477-B2 | Sirtuin activating compounds and processes for making the same | BRIGHAM YOUNG UNIVERSITY (US) | 2014-09-23 | — | — | US | disclosed |
| US-7833331-B2 | Non-toxic corrosion-protection pigments based on cobalt | UNIVERSITY OF DAYTON (US) | 2010-11-16 | — | — | US | disclosed |
| US-7789958-B2 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100185006-A1 | NOVEL SIRTUIN ACTIVATING COMPOUNDS AND PROCESSES FOR MAKING THE SAME | BRIGHAM YOUNG UNIVERSITY (US) | 2010-07-22 | — | — | US | disclosed |
| US-7714161-B2 | N-heterocyclic carbon-type ligand coupling in the presence of a base with benzyol halide and styrene coupling partners; resveratrol; increased stability for use in the food, cosmetic and pharmaceutical industries | BRIGHAM YOUNG UNIVERSITY (US) | 2010-05-11 | — | — | US | disclosed |
| US-20040016363-A1 | CORROSION-INHIBITING COATING | VENTURE LENDING & LEASING, IV, INC. | 2004-01-29 | — | — | US | disclosed |
| US-20040016910-A1 | Non-toxic corrosion-protection rinses and seals based on rare earth elements | DAYTON, UNIVERSITY OF | 2004-01-29 | — | — | US | disclosed |
| US-20040011252-A1 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON | 2004-01-22 | — | — | US | disclosed |
| US-20030234063-A1 | Non-toxic corrosion-protection conversion coats based on cobalt | DAYTON, UNIVERSITY OF | 2003-12-25 | — | — | US | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| WO-1992006059-A1 | PROCESS FOR MAKING OLEFINS | HENKEL RESEARCH CORPORATION (US) | 1992-04-16 | — | — | WO | disclosed |
| US-5077447-A | Decarbonylation of mixture of acid and anhydride using Group 8 metal or copper catalyst | HENKEL RESEARCH CORPORATION (US) | 1991-12-31 | — | — | US | disclosed |
| US-4289809-A | DEACTIVATION FOR BETTER SEPARATION OF POLAR COMPOUNDS | SCM CORPORATION (US) | 1981-09-15 | — | — | US | disclosed |
| US-4209554-A | PHOSPHONIUM SALTS | SCM CORPORATION (US) | 1980-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100185006-A1 | NOVEL SIRTUIN ACTIVATING COMPOUNDS AND PROCESSES FOR MAKING THE SAME | SIRT1, SIRT2, SIRT3 | CYP3A4 1022/4885TDP1 4448/4885ESR1 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.